Christopher Patusky - Jul 17, 2017 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Jul 17, 2017
Transactions value $
$529
Form type
4
Date filed
5/3/2023, 04:30 PM
Next filing
May 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Purchase $391 +3 +0.18% $130.24 1.68K Jul 17, 2017 Direct
transaction UTHR Common Stock Purchase $385 +3 +0.18% $128.35 1.69K Jul 28, 2017 Direct
transaction UTHR Common Stock Sale -$726 -6 -0.36% $121.01 1.68K Oct 20, 2017 Direct
transaction UTHR Common Stock Purchase $631 +5 +0.3% $126.20 1.69K Nov 20, 2017 Direct
transaction UTHR Common Stock Sale -$539 -5 -0.3% $107.71 1.68K Mar 20, 2018 Direct
transaction UTHR Common Stock Purchase $684 +6 +0.36% $114.06 1.69K Apr 20, 2018 Direct
transaction UTHR Common Stock Sale -$208 -2 -0.12% $104.12 1.68K May 21, 2018 Direct
transaction UTHR Common Stock Sale -$420 -4 -0.24% $105.11 1.68K Dec 28, 2018 Direct
transaction UTHR Common Stock Purchase $331 +4 +0.24% $82.83 1.68K Jun 10, 2019 Direct F1
holding UTHR Common Stock 1.1K Jul 17, 2017 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 reflects the reporting person's holdings as of May 3, 2023, the date of this Form 4.

Remarks:

The transactions reported in this Form 4 were executed by the reporting person's investment advisor in a managed account as part of the investment advisor's implementation of a large-cap investment strategy involving the securities of multiple issuers. The reporting person was unaware of the transactions at the time they occurred. Short swing profits resulting from these transactions have been returned to the Issuer.